Cardiovascular toxicity of targeted cancer therapies: Clinical considerations and potential mechanisms - B. Jensen - 20190925
When there is damage to the heart muscle, we call this cardiotoxicity. Brian Jensen, MD, will talk about underlying mechanisms for the cardiotoxicity of kinase inhibitors used to treat cancer.
UNCCN Mediasite Presenter
9/25/2019 3:30:00 PM
View

Mediasite Showcase
Mediasite's the trusted cornerstone of any campus or enterprise video strategy. Our unyielding commitment to all things video helps you transform education, training, communications and online events.
Webcasting Video Content Management Video Delivery Integration Services Mediasite Community
Powered By Mediasite - Enterprise Video Platform
Mediasite
Sonic Foundry